FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1473041000168100: Gliclazide MR (Pharmacor) (gliclazide 30 mg) modified release tablet, 60 tablets, bottle (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4410101000168110 Gliclazide MR (Pharmacor) (gliclazide 30 mg) modified release tablet, 60 tablets, bottle (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4410111000168113 Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle Is a Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60 true Inferred relationship Some
Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle Is a containered trade product pack true Inferred relationship Some
Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle has container type bottle true Inferred relationship Some
Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle has TP Gliclazide MR (Pharmacor) true Inferred relationship Some
Gliclazide MR (Pharmacor) 30 mg modified release tablet, 60, bottle has TPUU Gliclazide MR (Pharmacor) 30 mg modified release tablet true Inferred relationship Some 376967752

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start